News Releases

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting

March 27, 2023

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank

March 13, 2023

Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

March 2, 2023

Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology

February 27, 2023

Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board

February 21, 2023

Anixa Biosciences to Present at Biotech Showcase 2023

December 19, 2022

Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine

December 8, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium

November 8, 2022

Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy

October 31, 2022

Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic

October 26, 2022

Latest News & Events

Apr 29, 2026

Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology

Read More...

Apr 22, 2026

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting

Read More...

Apr 9, 2026

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026

Read More...